Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
This study has been withdrawn prior to enrollment.
(The study was cancelled by the sponsor prior to initiation of study enrollment. No subjects were accrued.)
First Posted: April 4, 2011
Last Update Posted: April 17, 2015
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||May 2012|
|Estimated Primary Completion Date:||August 2011 (Final data collection date for primary outcome measure)|